Abnormal activation of the PI3K/Akt/mTOR pathway is frequently observed in various types of human cancers and therefore targeting this pathway might represent a key therapeutic opportunity for the treatment of tumor [43]. The gene discussed is AKT1; the disease is neoplasm.